• Deferiprone Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, heavy-gauge HDPE bottles to ensure the absolute physical and chemical stability of the massive active pharmaceutical payload.

    Active IngredientStrengthPrimary Clinical Function
    Deferiprone USP/Ph.Eur.500 mgThe Standard Titration Unit: The baseline therapeutic dose utilized for precise, weight-based titration in pediatric and lower-weight thalassemia patients.
    Deferiprone USP/Ph.Eur.1000 mgThe Hematology Macrodose: The massive therapeutic payload required to minimize the total daily pill burden for adult patients suffering from severe, refractory iron overload.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced High-Shear Wet Granulation. Because a 1000mg tablet is inherently massive, it must be highly densified to remain swallowable, heavily coated to mask its severe bitterness, and packed with elite disintegrants to ensure it shatters instantly in the stomach)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 50 or 100 (Optimized specifically for massive, multi-pill daily chronic dispensing regimens).

  • Diloxanide furoate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Luminal-Dispersion Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the anti-parasitic ester.

    Active IngredientStrengthPrimary Clinical Function
    Diloxanide Furoate USP/Ph.Eur.500 mgThe Global Anti-Parasitic Standard: The definitive therapeutic macrodose utilized globally for the total luminal eradication of amoebic cysts in asymptomatic carriers and post-dysentery patients.
    ExcipientsMicrocrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced high-shear granulation and elite superdisintegrants to ensure the massive 500mg tablet shatters and disperses uniformly across the intestinal lining, maximizing physical contact with the embedded cysts)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, 10-day acute parasitology eradication regimens).

  • Doxophylline Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the xanthine derivative.

    Active IngredientStrengthPrimary Clinical Function
    Doxofylline USP/Ph.Eur.400 mgThe Global Pulmonology Standard: The definitive therapeutic macrodose utilized globally for the rapid and sustained reversal of severe bronchoconstriction in adult asthma and COPD patients.
    ExcipientsMicrocrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced rapid-burst disintegrants to ensure the massive 400mg tablet dissolves quickly in the stomach, while the heavy film-coat completely masks the intensely bitter taste characteristic of all xanthine alkaloids)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for strict chronic respiratory dispensing regimens).

  • Efavirenz Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the highly lipophilic active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Efavirenz USP/Ph.Eur.600 mgThe Global NNRTI Macrodose: The massive therapeutic payload required to force immediate, systemic viral suppression when combined with a dual-NRTI backbone.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Povidone K-30 / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Surfactant / Binder / Heavy Film-Coating (Engineered specifically utilizing powerful surfactants like Sodium Lauryl Sulfate to drastically increase the solubility of the notoriously lipophilic Efavirenz molecule, ensuring rapid and complete gastrointestinal absorption)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).

  • Flavoxate HCL Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active hydrochloride salt.

    Active IngredientStrengthPrimary Clinical Function
    Flavoxate Hydrochloride USP/Ph.Eur.200 mgThe Global Urological Standard: The definitive macrodose therapeutic unit utilized for rapid, acute suppression of agonizing bladder spasms and chronic overactive bladder maintenance.
    ExcipientsMicrocrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced “Rapid-Burst” superdisintegrants to ensure the massive 200mg tablet shatters instantly upon contact with gastric fluid, guaranteeing hyper-fast pain relief while masking the bitter taste)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-4 times daily acute dispensing regimens).